SSRIs: Applications in inflammatory lung disease and implications for COVID‐19

Selective serotonin reuptake inhibitors (SSRIs) have anti‐inflammatory properties that may have clinical utility in treating severe pulmonary manifestations of COVID‐19. SSRIs exert anti‐inflammatory effects at three mechanistic levels: (a) inhibition of proinflammatory transcription factor activity...

Descripción completa

Detalles Bibliográficos
Autores principales: Meikle, Claire Kyung Sun, Creeden, Justin Fortune, McCullumsmith, Cheryl, Worth, Randall G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411309/
https://www.ncbi.nlm.nih.gov/pubmed/34254465
http://dx.doi.org/10.1002/npr2.12194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411309/
https://www.ncbi.nlm.nih.gov/pubmed/34254465
http://dx.doi.org/10.1002/npr2.12194

Ejemplares similares